332 PEG feeding in adult people with CF – not always on the button? von Pandya, S, Walshaw, M.J

Volltext

21: The acute presentation of lung cancer – How well are we performing? von Hufton, A, Trafford, R, Smyth, C, Walshaw, M.J, Ledson, M

Volltext

44: Time to PET-CT and final pathology report – delays in the lung cancer pathway von Hufton, A, Trafford, R, Smyth, C, Walshaw, M.J, Ledson, M

Volltext

294 Exploring the utility of continuous glucose monitoring (CGMS) for cystic fibrosis related diabetes (CFRD) von Jackson, V.M, Dyce, P, Walshaw, M.J

Volltext

EPS3.9 Malignancy in cystic fibrosis: experience of a large adult CF unit von Trafford, R, Frost, F, Nazareth, D, Walshaw, M.J

Volltext

144 Casting aspersions on Aspergillus – a comparison of clinical disease markers and therapy in patients with and without ABPA von Spencer-Clegg, E, Sapina-Vivo, R, Walshaw, M.J

Volltext

352 Timely transplant referral – a holistic approach von Daniels, J, Sumner, C, Clarke, T, Walshaw, M.J

Volltext

165 How do CF patients cope with transition from Creon 40,000®? von Jurd, M, Pandya, S, Sobanska, A, Walshaw, M.J

Volltext

190 Use of a treatment algorithm to improve vitamin D status in cystic fibrosis – a review von Ochota, A, lurd, M, Pandya, S, Walshaw, M.J

Volltext

ePS04.7 A survey of activity levels and sedentary time in adult CF patients von Morris, A.R, Hilton, N.P, Greenwood, J, Ledson, M.J, Walshaw, M.J

Volltext

EPS3.8 Non-invasive liver tests in cystic fibrosis-related liver disease (CFLD) von Frost, F, Jones, G.H, Ledson, M.J, Nazareth, D, Walshaw, M.J, Greenwood, J

Volltext

187 Long-term continuous inhaled aztreonam (Cayston) BD von Frost, F, Sapina-Vivo, R, Nazareth, D, Greenwood, J, Ledson, M.J, Walshaw, M.J

Volltext

135 Is CF related diabetes associated with increased prevalence of Stenotrophomonas maltophilia ? von Frost, F, Fothergill, J, Shaw, M, Ledson, M.J, Greenwood, J, Winstanley, C, Walshaw, M.J

Volltext

185 Doxycycline vs. chloramphenicol for use in exacerbations of CF von Taylor, A, Frost, F, Ledson, M.J, Spencer-Clegg, E, Sapina-Vivo, R, Walshaw, M.J

Volltext

EPS6.5 Detecting changes in health in cystic fibrosis – a role for smartphones? von Frost, F, Trafford, R, Greenwood, J, Ledson, M.J, Nazareth, D, Walshaw, M.J

Volltext

270 Using patient understanding of four key areas of therapy to guide educational intervention von Jackson, M, Whitty, C, Greener, T, Morris, A, Hilton, N, Ledson, M, Walshaw, M.J

Volltext

259 Improving inpatient cystic fibrosis related diabetes (CFRD) care: The patients’ perspective von Pandya, S, Dyce, P, Walshaw, M.J

Volltext

169 The use of Airvo™ high flow humidification with cystic fibrosis patients – development of the service von Muggeridge, N, Lloyd, E.A, Walshaw, M.J, Greenwood, J

Volltext

184 Utility of an ultra-long acting insulin to treat cystic fibrosis related diabetes von Dyce, P, Jones, G.H, Walshaw, M.J

Volltext

247 CFRD education: What information do patients value and who do they ask? von Lamb, D.L, Dyce, P, Walshaw, M.J

Volltext